PetMed Total Revenue vs Cost Of Revenue Analysis

PETS Stock

USD 5.42 0.14 2.52%

PetMed Express financial indicator trend analysis is much more than just breaking down PetMed Express prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether PetMed Express is a good investment. Please check the relationship between PetMed Express Total Revenue and its Cost Of Revenue accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.

Total Revenue vs Cost Of Revenue

Total Revenue vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of PetMed Express Total Revenue account and Cost Of Revenue. At this time, the significance of the direction appears to have totally related.

The correlation between PetMed Express' Total Revenue and Cost Of Revenue is 0.99. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of PetMed Express, assuming nothing else is changed. The correlation between historical values of PetMed Express' Total Revenue and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of PetMed Express are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Total Revenue i.e., PetMed Express' Total Revenue and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

0.99

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Revenue

Total revenue comprises all receipts PetMed Express generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Cost Of Revenue

Cost of Revenue is found on PetMed Express income statement and represents the costs associated with goods and services PetMed Express provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from PetMed Express' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PetMed Express current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.At this time, PetMed Express' Selling General Administrative is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 464.80 in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.15 in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	78.1M	71.0M	71.6M	71.9M
Total Revenue	273.4M	256.9M	281.1M	214.1M

Gross Profit Total Revenue

PetMed Express fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Preferred Stock Total Equity
Total Assets		-0.54	0.29	0.56	0.94	0.73	-0.91	0.88	0.75	0.91	0.45	-0.52	0.9	0.76	0.67	0.59	0.01	0.42	0.55	0.41	0.54	0.61	0.93	-0.64	0.67	-0.04
Short Long Term Debt Total	-0.54		-0.48	-0.52	-0.59	-0.42	0.4	-0.59	-0.51	-0.36	-0.51	0.0	-0.43	-0.58	-0.95	-0.97	-0.25	-0.66	-0.51	-0.45	-0.5	-0.5	-0.54	0.92	-0.95	0.44
Other Current Liab	0.29	-0.48		0.93	0.07	0.44	-0.09	-0.05	0.74	0.05	0.93	0.31	0.02	0.32	0.43	0.3	0.71	0.08	0.81	0.76	0.94	0.77	0.06	-0.22	0.43	-0.92
Total Current Liabilities	0.56	-0.52	0.93		0.36	0.63	-0.41	0.25	0.94	0.37	0.93	0.02	0.34	0.46	0.49	0.37	0.56	0.18	0.89	0.73	1.0	0.86	0.37	-0.3	0.5	-0.81
Total Stockholder Equity	0.94	-0.59	0.07	0.36		0.68	-0.95	0.98	0.59	0.95	0.28	-0.63	0.96	0.72	0.68	0.67	-0.14	0.44	0.38	0.29	0.33	0.48	0.97	-0.69	0.67	0.1
Property Plant And Equipment Net	0.73	-0.42	0.44	0.63	0.68		-0.72	0.6	0.73	0.71	0.73	-0.27	0.62	0.56	0.48	0.39	0.25	-0.03	0.44	0.7	0.62	0.91	0.56	-0.35	0.48	-0.33
Net Debt	-0.91	0.4	-0.09	-0.41	-0.95	-0.72		-0.92	-0.66	-1.0	-0.3	0.67	-0.99	-0.62	-0.47	-0.46	0.12	-0.2	-0.41	-0.3	-0.38	-0.51	-0.94	0.46	-0.47	-0.07
Retained Earnings	0.88	-0.59	-0.05	0.25	0.98	0.6	-0.92		0.5	0.92	0.15	-0.67	0.95	0.69	0.65	0.68	-0.25	0.47	0.29	0.16	0.22	0.37	0.96	-0.7	0.65	0.17
Accounts Payable	0.75	-0.51	0.74	0.94	0.59	0.73	-0.66	0.5		0.63	0.8	-0.25	0.6	0.54	0.5	0.4	0.35	0.26	0.84	0.62	0.93	0.83	0.62	-0.36	0.51	-0.6
Cash	0.91	-0.36	0.05	0.37	0.95	0.71	-1.0	0.92	0.63		0.26	-0.69	0.99	0.62	0.44	0.43	-0.15	0.19	0.38	0.27	0.35	0.48	0.94	-0.45	0.44	0.12
Non Current Assets Total	0.45	-0.51	0.93	0.93	0.28	0.73	-0.3	0.15	0.8	0.26		0.14	0.2	0.46	0.5	0.35	0.64	0.02	0.74	0.86	0.93	0.95	0.21	-0.28	0.5	-0.85
Non Currrent Assets Other	-0.52	0.0	0.31	0.02	-0.63	-0.27	0.67	-0.67	-0.25	-0.69	0.14		-0.69	-0.45	-0.03	-0.08	0.46	-0.15	-0.06	0.17	0.04	-0.05	-0.65	0.11	-0.03	-0.33
Cash And Short Term Investments	0.9	-0.43	0.02	0.34	0.96	0.62	-0.99	0.95	0.6	0.99	0.2	-0.69		0.63	0.5	0.5	-0.19	0.29	0.37	0.2	0.32	0.4	0.97	-0.52	0.5	0.14
Net Receivables	0.76	-0.58	0.32	0.46	0.72	0.56	-0.62	0.69	0.54	0.62	0.46	-0.45	0.63		0.66	0.59	0.09	0.33	0.39	0.25	0.44	0.54	0.66	-0.64	0.66	-0.16
Common Stock Total Equity	0.67	-0.95	0.43	0.49	0.68	0.48	-0.47	0.65	0.5	0.44	0.5	-0.03	0.5	0.66		0.97	0.19	0.69	0.48	0.47	0.47	0.52	0.62	-0.97	1.0	-0.3
Common Stock Shares Outstanding	0.59	-0.97	0.3	0.37	0.67	0.39	-0.46	0.68	0.4	0.43	0.35	-0.08	0.5	0.59	0.97		0.1	0.71	0.39	0.34	0.34	0.39	0.62	-0.98	0.97	-0.23
Non Current Liabilities Total	0.01	-0.25	0.71	0.56	-0.14	0.25	0.12	-0.25	0.35	-0.15	0.64	0.46	-0.19	0.09	0.19	0.1		-0.15	0.49	0.57	0.58	0.5	-0.19	-0.04	0.2	-0.67
Inventory	0.42	-0.66	0.08	0.18	0.44	-0.03	-0.2	0.47	0.26	0.19	0.02	-0.15	0.29	0.33	0.69	0.71	-0.15		0.32	-0.04	0.15	0.0	0.49	-0.75	0.69	0.0
Other Current Assets	0.55	-0.51	0.81	0.89	0.38	0.44	-0.41	0.29	0.84	0.38	0.74	-0.06	0.37	0.39	0.48	0.39	0.49	0.32		0.55	0.88	0.65	0.44	-0.34	0.48	-0.67
Other Stockholder Equity	0.41	-0.45	0.76	0.73	0.29	0.7	-0.3	0.16	0.62	0.27	0.86	0.17	0.2	0.25	0.47	0.34	0.57	-0.04	0.55		0.74	0.84	0.19	-0.26	0.47	-0.68
Total Liab	0.54	-0.5	0.94	1.0	0.33	0.62	-0.38	0.22	0.93	0.35	0.93	0.04	0.32	0.44	0.47	0.34	0.58	0.15	0.88	0.74		0.86	0.34	-0.27	0.47	-0.82
Property Plant And Equipment Gross	0.61	-0.5	0.77	0.86	0.48	0.91	-0.51	0.37	0.83	0.48	0.95	-0.05	0.4	0.54	0.52	0.39	0.5	0.0	0.65	0.84	0.86		0.38	-0.32	0.52	-0.68
Total Current Assets	0.93	-0.54	0.06	0.37	0.97	0.56	-0.94	0.96	0.62	0.94	0.21	-0.65	0.97	0.66	0.62	0.62	-0.19	0.49	0.44	0.19	0.34	0.38		-0.65	0.62	0.12
Short Term Debt	-0.64	0.92	-0.22	-0.3	-0.69	-0.35	0.46	-0.7	-0.36	-0.45	-0.28	0.11	-0.52	-0.64	-0.97	-0.98	-0.04	-0.75	-0.34	-0.26	-0.27	-0.32	-0.65		-0.97	0.1
Common Stock	0.67	-0.95	0.43	0.5	0.67	0.48	-0.47	0.65	0.51	0.44	0.5	-0.03	0.5	0.66	1.0	0.97	0.2	0.69	0.48	0.47	0.47	0.52	0.62	-0.97		-0.3
Preferred Stock Total Equity	-0.04	0.44	-0.92	-0.81	0.1	-0.33	-0.07	0.17	-0.6	0.12	-0.85	-0.33	0.14	-0.16	-0.3	-0.23	-0.67	0.0	-0.67	-0.68	-0.82	-0.68	0.12	0.1	-0.3

Click cells to compare fundamentals

PetMed Express Account Relationship Matchups

PetMed Express fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	155.3M	187.5M	176.3M	164.1M	175.1M	97.5M
Other Current Liab	4.7M	5.4M	5.7M	11.3M	32.1M	33.7M
Total Current Liabilities	24.3M	44.9M	33.2M	36.5M	72.2M	75.8M
Total Stockholder Equity	130.0M	141.3M	142.2M	123.8M	96.7M	80.4M
Property Plant And Equipment Net	25.4M	25.5M	24.5M	26.2M	28.1M	29.5M
Net Debt	(103.8M)	(118.7M)	(111.1M)	(104.1M)	(53.8M)	(56.5M)
Retained Earnings	126.2M	134.1M	130.5M	105.5M	71.6M	72.0M
Accounts Payable	19.7M	39.5M	27.5M	25.2M	37.0M	38.9M
Cash	103.8M	118.7M	111.1M	104.1M	55.3M	47.6M
Non Current Assets Total	26.3M	26.3M	25.3M	32.7M	81.4M	85.5M
Non Currrent Assets Other	(26.3M)	(26.3M)	(25.3M)	5.9M	5.3M	5.5M
Cash And Short Term Investments	103.8M	118.7M	111.1M	104.1M	55.3M	52.5M
Net Receivables	3.8M	2.6M	1.9M	1.7M	3.3M	1.9M
Common Stock Shares Outstanding	20.1M	20.1M	20.4M	20.3M	20.4M	22.4M
Liabilities And Stockholders Equity	155.3M	187.5M	176.3M	164.1M	175.1M	97.5M
Non Current Liabilities Total	970K	1.3M	936K	3.8M	6.2M	6.5M
Inventory	17.9M	34.4M	32.5M	19.0M	28.6M	22.1M
Other Current Assets	3.5M	4.5M	5.5M	4.7M	6.5M	6.8M
Other Stockholder Equity	3.8M	7.1M	11.7M	18.3M	25.2M	26.4M
Total Liab	25.3M	46.2M	34.1M	40.3M	78.4M	82.3M
Property Plant And Equipment Gross	25.4M	25.5M	24.5M	26.2M	48.2M	50.6M
Total Current Assets	129.0M	161.2M	151.0M	131.5M	93.6M	79.0M
Property Plant Equipment	25.4M	25.5M	24.5M	26.2M	30.1M	31.6M
Net Tangible Assets	130.0M	141.3M	141.3M	123.8M	142.4M	114.5M
Retained Earnings Total Equity	126.2M	134.1M	130.5M	105.5M	121.3M	107.8M
Capital Surpluse	3.8M	7.1M	11.7M	18.3M	21.0M	22.1M
Other Liab	1.1M	970K	1.3M	936K	842.4K	852.3K
Net Invested Capital	130.0M	141.3M	142.2M	123.8M	96.7M	101.1M
Net Working Capital	104.7M	116.3M	117.8M	95.0M	21.5M	20.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for PetMed Stock Analysis

When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC